share_log

Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd.

Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd.

浩希健康科技有限公司獲得了3000萬人民幣的框架合同,爲騰源媒體廣告有限公司提供數字廣告服務。
GlobeNewswire ·  11/27 22:25

BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced the Company's wholly owned subsidiary Beijing Haoxi Digital Technology Co., Ltd. ("Beijing Haoxi") was awarded a Recharge Service Framework Contract (the "Contract") to provide comprehensive digital advertising services with a budget of RMB30 million for Tengyuan Media Advertising Co., Ltd. ("Tengyuan") and its clients.

北京,2024年11月27日(全球新聞網絡)——浩希健康科技有限公司("公司"或"HAO"),是一家總部位於中國北京的在線營銷解決方案提供商,今天宣佈公司全資子公司北京浩希數字科技有限公司("北京浩希")獲得了充值服務框架合同("合同"),爲騰源傳媒廣告有限公司("騰源")及其客戶提供綜合數字廣告服務,預算爲3000萬人民幣。

Pursuant to the Contract, Tengyuan has authorized Beijing Haoxi to produce customized internet marketing services through its network of media platforms that align with Tengyuan's unique business needs. Over the next year, Beijing Haoxi will also utilize its marketing expertise to help promote and enhance competitiveness for Tengyuan and its clients, according to the Contract.

根據合同,騰源授權北京浩希通過其媒體平台網絡製作定製的互聯網營銷服務,以滿足騰源獨特的業務需求。在接下來的一年中,北京浩希還將利用其營銷專業知識,幫助騰源及其客戶提升競爭力。

Mr. Zhen Fan, Chairman and Chief Executive Officer of the Company, stated that, "Partnering with Tengyuan is a pivotal milestone in our strategic roadmap. We look forward to enhancing our service capabilities and market position, ultimately delivering greater value for our clients."

公司董事長兼首席執行官範震表示:"與騰源的合作是我們戰略路線圖中的一個關鍵里程碑。我們期待着提升我們的服務能力和市場地位,最終爲我們的客戶提供更大的價值。"

"This Contract not only brings significant economic benefits to the Company but also supports our ongoing transformation to the digital marketing industry. We are confident that our collaboration with Tengyuan will help drive innovation and growth within the industry."

"這項合同不僅爲公司帶來了顯著的經濟利益,還支持我們持續向數字營銷行業的轉型。我們相信與騰源的合作將推動行業的創新和增長。"

About Haoxi Health Technology Limited

關於浩希健康科技有限公司

Haoxi Health Technology Limited is an online marketing solution provider headquartered in Beijing, China, specializing in serving healthcare industry advertiser clients. The Company's growth is driven by the rise of news feed ads and the rapid development of the healthcare sector. The Company offers one-stop online marketing solutions, especially in online short video marketing, helping advertisers acquire and retain customers on popular platforms in China, such as Toutiao, Douyin, WeChat, and Sina Weibo. The Company is dedicated to reducing costs, increasing efficiency, and providing easy online marketing solutions to advertisers. For more information, please visit:

浩希健康科技有限公司是一家總部位於中國北京的在線營銷解決方案提供商,專注於服務於醫療保健行業的廣告客戶。公司的增長得益於資訊流廣告的興起和醫療保健板塊的快速發展。公司提供一站式在線營銷解決方案,特別是在在線短視頻營銷方面,幫助廣告客戶在中國的熱門平台上獲取和留住客戶,如今日頭條、抖音、微信和新浪微博。公司致力於降低成本,提高效率,併爲廣告客戶提供簡便的在線營銷解決方案。欲了解更多信息,請訪問:

Forward-Looking Statement

前瞻性聲明

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of the registration statement filed with the U. S. Securities and Exchange Commission (the "SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

本新聞稿包含前瞻性聲明。前瞻性聲明包括涉及計劃、目標、目標、策略、未來事件或績效以及基本假設和其他非歷史事實的聲明。當公司使用"可能"、"將"、"打算"、"應該"、"相信"、"期望"、"預期"、"預測"、"估計"或類似表達與歷史事實無關的言辭時,它正在進行前瞻性聲明。前瞻性聲明不是對未來績效的保證,涉及風險和不確定性,可能導致實際結果大爲不同於公司在前瞻性聲明中討論的期望。這些聲明受到不確定性和風險的影響,包括但不限於市場狀況的不確定性,以及在向美國證券交易委員會(SEC)提交的註冊聲明中討論的其他因素在"風險因素"部分。因此,出於這些原因等其他原因,我們警告投資者不要過度依賴本新聞稿中的任何前瞻性聲明。有關更多因素,請參閱公司在SEC的文件,可在www.sec.gov上查閱。公司無義務公開修改這些前瞻性聲明,以反映本次日期之後出現的事件或情況。

For more information, please contact:
Investor Relations
WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email: services@wealthfsllc.com
Phone: +86 13811768599
+1 628 283 9214

更多信息,請聯繫:
投資者關係
WFS投資者關係公司
Janice Wang,管理合夥人
電子郵件:services@wealthfsllc.com
電話:+86 13811768599
+1 628 283 9214


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論